ADIPOQ and breast neoplasm: ADP 355 showed high affinity with AdipoR1, and through the regulation of the canonical adiponectin-regulated pathways (i.e., AMPK, Akt, STAT3, and ERK1/2), reduced breast tumor growth both in in vitro and in vivo studies [162,163].